Μπορείτε να στέλνετε ειδήσεις και Δελτία Τύπου στο email μας.
Αν θέλετε να επικοινωνήσετε μαζί μας ή να στείλετε Δελτίο Τύπου πατήστε εδώ...pharmamarketingexpertsblog@gmail.com


Παρασκευή 27 Σεπτεμβρίου 2013

Pfizer begins using ‘digital’ reps

Pfizer has begun using digital drug representatives to market medicines, leaving the decision as to whether they want to see them in doctors’ hands. It’s an unusual move that creates more of an indirect form of marketing. The firm’s new service it calls ‘Pfizerline’ has its own website with a blurb saying: “Ask Pfizer............, who can give you promotional product information at a time convenient to you. It’s simple. It’s flexible. It’s convenient. Calls can be arranged to suit your busy practice schedule.” 

 The service offers new ways for primary care doctors to talk to reps and also offers links to product information about branded medicines available in the UK. 

Market Access is Dead: Patient Access is the New Prescription for Healthcare Marketing

 
by John Glasspool 
 
Paradigms change when questions emerge the old paradigm can no longer answer. Market access has become a buzz word as access to markets is as significant a hurdle to product usage as registration itself. Initially a topic for pharmaceutical companies concerned about volume, it now affects all aspects of healthcare. We believe that the current understanding of market access will undergo a fundamental shift of perspective away from a company-centered towards a patient-centered view of the problem. This article identifies several forces that challenge the current understanding of market access and lobbies for a patient-centered, comprehensive approach that aims to address the needs of all stakeholders, but primarily create value for patients: Patient Access. 

What killed market access?
 
There are four reasons why the current approach to market access is doomed to fail:

Marketer of the Year - Finalists




Aspiring Marketer
Alice Bamford
TEVA UK
Neil Imrie
Janssen
Nathan Tembey
Lundbeck
 Alison Ford
 Napp Pharmaceuticals
 Emma Gulliver
Shire Pharmaceuticals
 Thomas Renwick
Roche
 Jordan Millar
AstraZeneca
 Cyrus Colabawalla
Abbvie
 Simon Evans
Napp Pharmaceuticals
 James Burrow
Lundbeck



New Marketer
Nicola Cameron
Stiefel, a GSK Company
Jeannette Storey
Novo Nordisk
Simon Barras
Nordic Pharma
 Andrew Jackson
 Lundbeck
 Robert Preece
 Grunenthal
 Angela Renshaw
 Baxter Healthcare
 Mark McLaughlin
Abbvie
 Adam Chapman
 Lundbeck
 Rachel Welbank
Abbvie
 Christina Littman
Merck Serono



Senior Marketer - UK
Jenni Breadner
Abbott Healthcare
Matthew Kiely
 Celgene
Chris Milne
Merck Serono
 Niki Papadiki
 TEVA UK
 Gary Durkin
TEVA UK
 Stacey East
 Baxter Healthcare
 Michael Short
 Merck Serono
 David Styles
 Merck Serono
 Fiona Hooper
Bayer
 Hannah Watson
 Abbvie
 David Payne
 Celgene
 Jamie Cairns
 Lilly
 Karen Hobdell
 Shire Pharmaceuticals
 Andrew Smith
 TEVA UK


Senior Marketer - Non UK
Nikhil Nadarkhani
RPG Life Science
Eivor Orenmark
Shire Pharmaceuticals, Nordic
Aurelie Lapierre
Shire Pharmaceuticals, France
 Laura Ameri
 Shire Pharmaceuticals Italy
 Simona Biondi
 Shire Pharmaceuticals Italy
 Nagina Elahi
 Eisai BV
 Julia Beba
Servier
 Krzysztof Ramzia
 Actelion Pharma
 Wojciech Kosior
 Bayer
 Denise Meyer
 Millenium Pharmaceuticals
 Audrey Laurisse
Viiv Healthcare
 Mohd Suhail
Glenmark Pharmaceuticals
 Artur Krzyzanowski
 Bristol Myers Squibb



Aspiring Marketing Manager
Louise Byrne
Roche
Sally Williamson
Janssen
Brad Miller
XenoTech
 Emma Clayton
 CSL Behring UK
 Lance Boyd-Clark
Lundbeck
 Deborah Vaughan
TEVA UK
 
Marketing Team
Baxter Healthcare
Shire Pharmaceuticals
Lundbeck
 Napp Pharmaceuticals
 Abbott Healthcare
 TEVA UK 1
 TEVA UK 2
 A.Menarini Farmaceutica Internazionale SRL





Φαρμακευτικο Μαρκετινγκ: Θεωρια, Πρακτικη, Δεοντολογια

The ultimate guide for Pharma Marketing Champions
Ζητήστε το στα κεντρικά βιβλιοπωλεία ή δώστε την παραγγελία σας τώρα